Sign Up to like & get
recommendations!
0
Published in 2021 at "Vaccine"
DOI: 10.1016/j.vaccine.2021.02.049
Abstract: BACKGROUND Meningococcal serogroup B (MenB) has emerged as the leading cause of invasive meningococcal disease (IMD) in several countries following the release of effective vaccines against serogroups A, C, W, and Y. In 2013, however,…
read more here.
Keywords:
menb;
meningococcal serogroup;
serogroup menb;
menb vaccines ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Vaccine"
DOI: 10.1016/j.vaccine.2021.06.005
Abstract: BACKGROUND To demonstrate extended protection against meningococcal serogroup B (MenB) disease after MenB-FHbp (bivalent rLP2086) vaccination, this study evaluated immunopersistence through 26 months following MenB-FHbp boosting after 2 or 3 primary doses in adolescents. STUDY DESIGN…
read more here.
Keywords:
menb;
menb fhbp;
persistence;
booster ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Expert Review of Vaccines"
DOI: 10.1080/14760584.2019.1578217
Abstract: ABSTRACT Introduction: Invasive meningococcal disease (IMD) can be devastating; it is associated with high case fatality rates and long-term sequelae among many survivors. Five serogroups (A, B, C, W, and Y) cause nearly all IMD…
read more here.
Keywords:
menb;
introduction;
fhbp;
epidemiology ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of Clinical Microbiology"
DOI: 10.1128/jcm.00204-18
Abstract: A recombinant NadA protein is one of the four major protective antigens of 4C-MenB (Bexsero), a vaccine developed for serogroup B Neisseria meningitidis (MenB). The meningococcal antigen typing system (MATS) is utilized as a high-throughput…
read more here.
Keywords:
menb;
phase;
repeat numbers;
repeat ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0282971
Abstract: Invasive meningococcal disease belongs among the most dangerous infectious diseases in the world. Several polysaccharide conjugate vaccines against serogroups A, C, W and Y are available and two recombinant peptide vaccines against serogroup B (MenB…
read more here.
Keywords:
invasive meningococcal;
czech republic;
coverage;
meningococcal disease ... See more keywords